Leigh MacMillan Archive — Page 55 of 85

Silhouetted person wearing a backpack and looking through binoculars while standing on a grassy ridge against an orange sky.
May 5, 2016

Current cancer drug discovery method flawed: VUMC study

The primary method used to test compounds for anti-cancer activity in cells is flawed, Vanderbilt University researchers reported May 2 in Nature Methods.

By Leigh MacMillan
Medical-style illustration of a translucent human figure with a glowing highlighted area in the brain.
May 3, 2016

Drug combos for glioblastoma

Vanderbilt researchers have discovered that activation of a certain signaling pathway protects brain cancers from targeted therapies, suggesting that using therapeutics that block both pathways may be a promising treatment.

By Leigh MacMillan
Black-and-white sketch portrait of a man in a collared shirt and suit jacket.
April 28, 2016

Cancer expert Thompson to deliver May 5 Flexner Discovery Lecture

Craig Thompson, M.D., president and CEO of Memorial Sloan Kettering Cancer Center, will deliver the next Flexner Discovery Lecture on May 5.

By Leigh MacMillan
Black-and-white sketch portrait of a man, identified by the caption as Eric Betzig, Ph.D.
April 21, 2016

Nobel laureate Betzig set for Discovery Lecture

Eric Betzig, Ph.D., who shared the 2014 Nobel Prize in Chemistry for the development of super-resolved fluorescence microscopy, will deliver the next Flexner Discovery Lecture on April 28.

By Leigh MacMillan
Illustration of a neuron with a branching cell body, central nucleus, elongated myelinated axon, and terminal ending against a blurred green background.
April 19, 2016

Myelin repair factors

Vanderbilt researchers show that two factors promote the repair of myelin, the nerve cell covering that deteriorates in diseases such as multiple sclerosis.

By Leigh MacMillan
Close-up of a person using a white inhaler held to their mouth.
April 5, 2016

Immune defenses in asthma

Vanderbilt researchers show that a certain factor negatively impacts the first-line responder cells in the lungs, providing one explanation for why patients with asthma are at greater risk for invasive bacterial disease.

By Leigh MacMillan